IDUN Technologies raises €1.8M Seed round
2 September 2021· Opfikon, Switzerland· health, neurotechnology, ai, materials, b2b, software_hardware
The capital will flow into validating its biomarkers with strategic partners like Takeda and other companies in strategic market segments such as sleep health and assisted hearing. The seed round extension will enable the company and its 15 engineers to validate its brain biomarkers through customer projects and technology advancement and build unique brain data interpretation algorithms.
Investors
LeadMICA Ventures
Also participating
CADFEMSwiss Startup GroupWieInvestJoyance PartnersPrivilege Venturesthink future GmbH
About IDUN Technologies
Stage
Seed
Headquarters
Opfikon, Switzerland
Founded
2017
Team Size
21–50
Sectors
healthneurotechnologyaimaterialsb2bsoftware_hardware